Q9BUR5
Gene name |
APOO |
Protein name |
MICOS complex subunit MIC26 |
Names |
Apolipoprotein O, MICOS complex subunit MIC23, Protein FAM121B |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:79135 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9BUR5
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9BUR5-F1 | Predicted | AlphaFoldDB |
132 variants for Q9BUR5
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs1373428884 CA412590560 CA412590559 |
2 | F>L | No |
ClinGen TOPMed gnomAD |
|
|
rs746341693 CA10370225 |
2 | F>L | No |
ClinGen ExAC gnomAD |
|
|
rs1178487551 CA412590557 |
3 | K>E | No |
ClinGen TOPMed gnomAD |
|
|
rs779439514 CA10370224 CA412590552 |
3 | K>N | No |
ClinGen ExAC gnomAD |
|
|
rs1178487551 CA412590558 |
3 | K>Q | No |
ClinGen TOPMed gnomAD |
|
|
rs1441379176 CA412590222 |
8 | S>F | No |
ClinGen gnomAD |
|
|
CA10370211 rs760203325 |
9 | V>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs760203325 CA10370210 |
9 | V>M | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs775228231 CA10370209 |
10 | G>E | No |
ClinGen ExAC gnomAD |
|
|
rs145969741 CA10370208 |
12 | A>G | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs145969741 CA412590201 |
12 | A>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs867988889 CA327666328 |
13 | S>N | No |
ClinGen gnomAD |
|
|
rs1332210902 CA412590194 |
13 | S>R | No |
ClinGen gnomAD |
|
|
CA10370207 rs200861085 |
15 | S>C | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA327666327 rs142397778 |
15 | S>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA327666326 rs997987273 |
16 | L>S | No |
ClinGen TOPMed |
|
|
rs778448830 CA10370202 |
19 | F>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA10370203 rs137876219 |
19 | F>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA412590153 rs1455539263 |
20 | K>R | No |
ClinGen gnomAD |
|
|
CA412590140 rs1326650969 |
22 | Y>C | No |
ClinGen gnomAD |
|
|
rs752839065 CA10370201 |
22 | Y>N | No |
ClinGen ExAC |
|
|
CA412590121 rs1392516908 |
25 | P>R | No |
ClinGen gnomAD |
|
|
CA327666325 rs895600235 |
25 | P>S | No |
ClinGen gnomAD |
|
| TCGA novel | 27 | K>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs758122885 CA10370199 |
30 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1375144328 CA412590061 |
34 | S>P | No |
ClinGen gnomAD |
|
|
rs149224639 CA10370196 |
35 | V>M | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA327666323 rs898805201 |
36 | K>N | No |
ClinGen TOPMed gnomAD |
|
|
CA412590041 rs1194924421 |
37 | V>A | No |
ClinGen gnomAD |
|
|
CA10370195 rs753855299 |
37 | V>F | No |
ClinGen ExAC gnomAD |
|
|
rs138309366 CA10370194 |
39 | E>K | No |
ClinGen ESP ExAC |
|
|
rs1322784408 CA412590010 |
40 | L>F | No |
ClinGen TOPMed |
|
|
rs150456705 CA10370174 |
42 | L>P | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA10370171 rs766709410 |
43 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs774016397 CA10370172 |
43 | Y>D | No |
ClinGen ExAC gnomAD |
|
|
CA10370169 rs140548900 |
45 | V>F | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1232404554 CA412589968 |
47 | E>G | No |
ClinGen gnomAD |
|
|
rs868511129 CA327666166 |
50 | S>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
CA412589949 rs1222559316 |
50 | S>P | No |
ClinGen TOPMed |
|
|
rs371968593 CA10370166 |
51 | K>E | No |
ClinGen ESP ExAC gnomAD |
|
|
rs1330211920 CA412589933 |
52 | Y>C | No |
ClinGen TOPMed |
|
|
rs1240835837 CA412589908 |
56 | A>T | No |
ClinGen TOPMed |
|
| TCGA novel | 60 | L>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs868494655 CA327666165 |
63 | S>I | No |
ClinGen gnomAD |
|
|
rs979506043 CA327666164 |
64 | I>F | No |
ClinGen Ensembl |
|
|
rs1187573563 CA412589828 |
67 | L>F | No |
ClinGen TOPMed |
|
|
rs969032515 CA327666163 |
68 | R>Q | No |
ClinGen Ensembl |
|
|
rs1401937457 CA412589820 |
69 | H>N | No |
ClinGen gnomAD |
|
|
rs199760059 CA10370163 |
71 | C>W | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1408505402 CA412589794 |
72 | E>G | No |
ClinGen TOPMed |
|
|
rs182125234 CA10370162 |
72 | E>K | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA10370161 rs191045469 |
74 | Y>H | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA10370160 rs757259211 |
75 | T>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs756017165 CA10370159 |
76 | T>S | No |
ClinGen ExAC gnomAD |
|
|
CA412589754 rs1259370923 |
78 | C>F | No |
ClinGen gnomAD |
|
|
CA10370158 rs752608145 |
78 | C>R | No |
ClinGen ExAC gnomAD |
|
|
CA10370142 rs769499730 |
80 | E>D | No |
ClinGen ExAC gnomAD |
|
|
CA10370141 rs748097340 COSM305972 |
81 | T>M | lung haematopoietic_and_lymphoid_tissue [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
|
CA10370139 rs754478339 |
84 | Q>P | No |
ClinGen ExAC gnomAD |
|
|
CA327665787 rs966841857 |
89 | M>L | No |
ClinGen Ensembl |
|
|
rs751126282 CA10370138 |
90 | Q>E | No |
ClinGen ExAC gnomAD |
|
|
CA10370137 rs779552153 |
90 | Q>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA412588724 rs1261769493 |
93 | V>F | No |
ClinGen TOPMed |
|
| TCGA novel | 95 | W>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs757978777 CA10370136 |
96 | G>R | No |
ClinGen ExAC gnomAD |
|
|
CA327665786 rs866052403 |
96 | G>V | No |
ClinGen Ensembl |
|
|
CA412588649 rs1275329087 |
97 | L>F | No |
ClinGen gnomAD |
|
|
CA412587731 rs1271863125 |
98 | D>E | No |
ClinGen gnomAD |
|
|
rs1255069164 CA412587721 |
99 | S>I | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs1219687738 CA412587716 |
100 | Y>H | No |
ClinGen TOPMed gnomAD |
|
|
rs768521438 CA10370119 |
102 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA10370120 rs768521438 |
102 | Y>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1274167613 CA412587675 |
103 | L>V | No |
ClinGen TOPMed gnomAD |
|
|
rs1340618914 CA412587624 |
107 | P>S | No |
ClinGen gnomAD |
|
|
rs768859557 CA10370117 |
109 | G>R | No |
ClinGen ExAC gnomAD |
|
|
CA10370116 rs200271508 |
109 | G>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA10370114 rs769784742 |
112 | P>L | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs769784742 CA10370115 |
112 | P>Q | No |
ClinGen 1000Genomes ExAC gnomAD |
|
| TCGA novel | 114 | L>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA327665340 rs372937215 |
115 | G>C | No |
ClinGen ESP |
|
|
CA10370112 rs754095247 |
116 | V>A | No |
ClinGen ExAC gnomAD |
|
|
rs1156282150 CA412587527 |
116 | V>I | No |
ClinGen TOPMed |
|
|
CA412587508 rs1277689417 |
117 | I>M | No |
ClinGen gnomAD |
|
|
rs1330638852 CA412587494 |
119 | F>L | No |
ClinGen TOPMed gnomAD |
|
|
CA327665339 rs1030700096 |
121 | G>A | No |
ClinGen TOPMed gnomAD |
|
|
rs756652973 CA10370110 |
123 | I>V | No |
ClinGen ExAC gnomAD |
|
|
rs1322310170 CA412587423 |
125 | L>P | No |
ClinGen TOPMed |
|
|
CA10370109 rs748623374 |
128 | A>T | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA327664447 rs746077713 |
134 | K>R | No |
ClinGen Ensembl |
|
|
rs200622657 CA327664446 |
137 | V>M | No |
ClinGen Ensembl |
|
|
COSM3560475 rs369973145 CA10370096 |
139 | P>L | Variant assessed as Somatic; 0.0 impact. prostate [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ESP ExAC NCI-TCGA TOPMed gnomAD |
|
CA412585857 rs1350592965 |
139 | P>S | No |
ClinGen TOPMed |
|
|
rs756796573 CA10370095 |
141 | G>A | No |
ClinGen ExAC gnomAD |
|
|
CA412585820 rs1408923895 |
142 | F>V | No |
ClinGen TOPMed gnomAD |
|
|
CA412585805 rs1179198181 |
143 | M>V | No |
ClinGen gnomAD |
|
|
CA412585783 rs377243454 |
144 | G>E | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA10370094 rs377243454 |
144 | G>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA10370093 rs778237433 |
145 | L>I | No |
ClinGen ExAC gnomAD |
|
|
rs1219731218 CA412585772 |
145 | L>S | No |
ClinGen TOPMed |
|
|
rs756595892 CA10370092 |
147 | A>V | No |
ClinGen ExAC gnomAD |
|
|
rs373225462 CA10370091 |
148 | S>C | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA327664445 rs373225462 |
148 | S>F | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA10370090 rs373225462 |
148 | S>Y | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA412585700 rs1208795156 |
150 | Y>C | No |
ClinGen gnomAD |
|
|
rs147913865 CA10370087 |
154 | Q>K | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA10370085 rs373029808 |
157 | V>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA10370084 rs763850598 |
159 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 160 | Q>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1042351843 CA327664444 |
160 | Q>R | No |
ClinGen gnomAD |
|
| TCGA novel | 162 | S>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs759130534 CA327664301 |
164 | E>* | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs759130534 CA10370066 |
164 | E>K | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs767818111 CA327664300 |
166 | L>F | No |
ClinGen Ensembl |
|
|
CA10370065 RCV000961791 rs75916244 |
166 | L>V | No |
ClinGen ClinVar 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
|
CA10370063 rs752425092 |
172 | R>* | No |
ClinGen ExAC gnomAD |
|
|
CA10370062 rs142355722 |
172 | R>Q | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
| TCGA novel | 173 | G>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs781675242 CA10370061 |
173 | G>R | No |
ClinGen ExAC gnomAD |
|
|
rs774399318 CA10370060 |
174 | Y>C | No |
ClinGen ExAC gnomAD |
|
|
rs770317076 CA10370059 |
175 | I>V | No |
ClinGen ExAC gnomAD |
|
|
CA412590438 rs1418432046 |
176 | V>I | No |
ClinGen TOPMed |
|
|
CA412590430 rs1182381423 |
177 | I>T | No |
ClinGen TOPMed |
|
|
rs755451321 CA10370058 |
179 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1333833563 CA412590411 |
180 | L>V | No |
ClinGen TOPMed gnomAD |
|
|
rs1172747969 CA412590389 |
182 | K>N | No |
ClinGen TOPMed |
|
|
CA327664299 rs969409759 |
183 | E>K | No |
ClinGen TOPMed |
|
|
CA412590381 rs1435558569 |
184 | N>D | No |
ClinGen TOPMed |
|
|
CA10370057 rs772988801 |
186 | Q>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA327664298 rs267606421 |
187 | K>N | No |
ClinGen Ensembl |
|
|
CA10370044 rs757432410 |
189 | G>E | No |
ClinGen ExAC gnomAD |
|
|
CA412590333 rs1266277942 |
189 | G>R | No |
ClinGen gnomAD |
|
|
rs908435383 CA327663007 |
197 | T>A | No |
ClinGen TOPMed |
No associated diseases with Q9BUR5
Functions
15 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
| extracellular region | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| Golgi membrane | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| high-density lipoprotein particle | A lipoprotein particle with a high density (typically 1.063-1.21 g/ml) and a diameter of 5-10 nm that contains APOAs and may contain APOCs and APOE; found in blood and carries lipids from body tissues to the liver as part of the reverse cholesterol transport process. |
| integral component of mitochondrial inner membrane | The component of the mitochondrial inner membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| low-density lipoprotein particle | A lipoprotein particle, rich in cholesterol esters and low in triglycerides that is typically composed of APOB100 and APOE and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. LDL particles are formed from VLDL particles (via IDL) by the loss of triglyceride and gain of cholesterol ester. They transport endogenous cholesterol (and to some extent triglycerides) from peripheral tissues back to the liver. |
| MIB complex | A mitochondrial intermembrane space bridging complex consisting of components of the MICOS complex in the inner mitochondrial membrane, the SAM complex in the outer membrane, a conserved DNAJ protein (human DNAJC11) and Metaxin 1. |
| MICOS complex | Mitochondrial inner membrane complex involved in maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. In Saccharomyces cerevisiae the complex has six subunits: MIC10, MIC12, MIC19, MIC26, MIC27, and MIC60. |
| mitochondrial crista junction | A tubular structure of relatively uniform size that connects a mitochondrial crista to the mitochondrial inner boundary membrane. |
| mitochondrial inner membrane | The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. |
| mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| SAM complex | A large complex of the mitochondrial outer membrane that mediates sorting of some imported proteins to the outer membrane and their assembly in the membrane; functions after import of incoming proteins by the mitochondrial outer membrane translocase complex. |
| very-low-density lipoprotein particle | A triglyceride-rich lipoprotein particle that is typically composed of APOB100, APOE and APOCs and has a density of about 1.006 g/ml and a diameter of between 20-80 nm. It is found in blood and transports endogenous products (newly synthesized cholesterol and triglycerides) from the liver. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| cristae formation | The assembly of cristae, the inwards folds of the inner mitochondrial membrane. |
| inner mitochondrial membrane organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the mitochondrial inner membrane. |
| lipid transport | The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MFKVIQRSVG | PASLSLLTFK | VYAAPKKDSP | PKNSVKVDEL | SLYSVPEGQS | KYVEEARSQL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| EESISQLRHY | CEPYTTWCQE | TYSQTKPKMQ | SLVQWGLDSY | DYLQNAPPGF | FPRLGVIGFA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| GLIGLLLARG | SKIKKLVYPP | GFMGLAASLY | YPQQAIVFAQ | VSGERLYDWG | LRGYIVIEDL |
| 190 | |||||
| WKENFQKPGN | VKNSPGTK |